AI-Designed Cancer Drugs: Isomorphic Labs to Begin Human Trials
Isomorphic Labs, backed by Google's parent Alphabet, is set to begin human trials for cancer drugs designed entirely by AI, marking a pivotal moment in medicine.
posted on 07/09/2025
Isomorphic Labs, backed by Google's parent Alphabet, is set to begin human trials for cancer drugs designed entirely by AI, marking a pivotal moment in medicine.
posted on 07/09/2025
Alphabet CEO Sundar Pichai addresses concerns about AI replacing jobs, highlighting AI's role in boosting productivity and driving growth.
posted on 06/05/2025